{"schema_version":"secwatch.filing_event.v1","accession":"0001818331-22-000053","form_type":"8-K","ticker":"WGS","cik":"0001818331","company_name":"GeneDx Holdings Corp.","filed_at":"2022-06-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.475876+00:00","generated_at":"2026-06-25T02:05:13.898195+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Sema4 CFO Isaac Ro to depart Aug. 9, 2022; Richard Miao named interim CFO","bullets":["CFO Isaac Ro to leave Aug. 9, 2022; entitled to 9 months salary continuation and 12 months COBRA.","Richard Miao, SVP of FP&A and Treasurer, promoted to Deputy CFO and Interim CFO effective June 13.","Ro enters 6-month consulting agreement for advisory services with continued equity vesting.","Company reaffirms financial guidance provided May 12, 2022; search for permanent CFO engaged via Russell Reynolds.","Amendment extends Dr. Eric Schadt's 'Good Reason' notice period through April 28, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001818331-22-000053","json":"https://secwatch.observer/filing/0001818331-22-000053.json","markdown":"https://secwatch.observer/filing/0001818331-22-000053.md","text":"https://secwatch.observer/filing/0001818331-22-000053.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818331/000181833122000053/0001818331-22-000053-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818331/000181833122000053/smfr-20220610.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T02:05:13.898195+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"271b9767d0","claim":"Isaac Ro resigned as Chief Financial Officer at GeneDx Holdings Corp..","evidence_excerpt":"its Chief Financial Officer, Isaac Ro, will leave the Company to pursue other career opportunities.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1818331/000181833122000053/0001818331-22-000053-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"3f7be62ca1","claim":"Richard Miao was appointed as Interim Chief Financial Officer at GeneDx Holdings Corp..","evidence_excerpt":"Richard Miao, the Company’s current Senior Vice President of Financial Planning & Analysis and Treasurer, was promoted to Deputy Chief Financial Officer and appointed to serve as the Interim Chief Financial Officer, effective June 13, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1818331/000181833122000053/0001818331-22-000053-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}